Regulation of heme oxygenase expression by cyclopentenone prostaglandins

Hean Zhuang, Sokhon Pin, Xiaoling Li, Sylvain Doré

Research output: Contribution to journalArticle

Abstract

Prostaglandins (PGs) originate from the degradation of membranar arachidonic acid by cyclooxygenases (COX-1 and COX-2). The prostaglandin actions in the nervous system are multiple and have been suggested to play a significant role in neurodegenerative disorders. Some PGs have been reported to be toxic and, interestingly, the cyclopentenone PGs have been reported to be cytoprotective at low concentration and could play a significant role in neuronal plasticity. They have been shown to be protective against oxidative stress injury; however, the cellular mechanisms of protection afforded by these PGs are still unclear. It is postulated that the cascade leading to neuronal cell death in acute and chronic neurodegenerative conditions, such as cerebral ischemia and Alzheimer's disease, would be mediated by free radical damage. We tested the hypothesis that the neuroprotective action of cyclopentanone could be caused partially by an induction of heme oxygenase 1 (HO-1). We and others have previously reported that modulation of HO total activity may well have direct physiological implications in stroke and in Alzheimer's disease. HO acts as an antioxidant enzyme by degrading heme into iron, carbon monoxide, and biliverdin that is rapidly converted into bilirubin. Using mouse primary neuronal cultures, we demonstrated that PGs of the J series induce HO-1 in a dose-dependent manner (0, 0.5, 5, 10, 20, and 50 μg/ml) and that PGJ 2 and dPGJ2 were more potent than PGA2, dPGA2, PGD2, and PGE2. No significant effects were observed for HO-2 and actin expression. In regard to HO-3 expression found in rat, with its protein deducted sequence highly homologous to HO-2, no detection was observed in HO-2-/- mice, suggesting that HO-3 protein would not be present in mouse brain. We are proposing that several of the protective effects of PGJ2 could be mediated through beneficial actions of heme degradation and its metabolites. The design of new mimetics based on the cyclopentenone structure could be very useful as neuroprotective agents and be tested in animal models of stroke and Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)499-505
Number of pages7
JournalExperimental Biology and Medicine
Volume228
Issue number5
StatePublished - May 2003

Fingerprint

Heme Oxygenase (Decyclizing)
Prostaglandins
Alzheimer Disease
Heme Oxygenase-1
Heme
Stroke
Biliverdine
Prostaglandin D2
Degradation
Cyclooxygenase 1
Neuronal Plasticity
Oxidative stress
Poisons
Neurology
Neuroprotective Agents
Cell death
Carbon Monoxide
Prostaglandin-Endoperoxide Synthases
Sequence Homology
Metabolites

Keywords

  • Alzheimer's disease
  • Antioxidant
  • Cerebral ischemia
  • Free radical
  • Iron
  • Neurodegeneration
  • Oxidative stress
  • Prostaglandin
  • Stroke

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Zhuang, H., Pin, S., Li, X., & Doré, S. (2003). Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Experimental Biology and Medicine, 228(5), 499-505.

Regulation of heme oxygenase expression by cyclopentenone prostaglandins. / Zhuang, Hean; Pin, Sokhon; Li, Xiaoling; Doré, Sylvain.

In: Experimental Biology and Medicine, Vol. 228, No. 5, 05.2003, p. 499-505.

Research output: Contribution to journalArticle

Zhuang, H, Pin, S, Li, X & Doré, S 2003, 'Regulation of heme oxygenase expression by cyclopentenone prostaglandins', Experimental Biology and Medicine, vol. 228, no. 5, pp. 499-505.
Zhuang, Hean ; Pin, Sokhon ; Li, Xiaoling ; Doré, Sylvain. / Regulation of heme oxygenase expression by cyclopentenone prostaglandins. In: Experimental Biology and Medicine. 2003 ; Vol. 228, No. 5. pp. 499-505.
@article{790f9b145ad34fd8aee753a646cf4684,
title = "Regulation of heme oxygenase expression by cyclopentenone prostaglandins",
abstract = "Prostaglandins (PGs) originate from the degradation of membranar arachidonic acid by cyclooxygenases (COX-1 and COX-2). The prostaglandin actions in the nervous system are multiple and have been suggested to play a significant role in neurodegenerative disorders. Some PGs have been reported to be toxic and, interestingly, the cyclopentenone PGs have been reported to be cytoprotective at low concentration and could play a significant role in neuronal plasticity. They have been shown to be protective against oxidative stress injury; however, the cellular mechanisms of protection afforded by these PGs are still unclear. It is postulated that the cascade leading to neuronal cell death in acute and chronic neurodegenerative conditions, such as cerebral ischemia and Alzheimer's disease, would be mediated by free radical damage. We tested the hypothesis that the neuroprotective action of cyclopentanone could be caused partially by an induction of heme oxygenase 1 (HO-1). We and others have previously reported that modulation of HO total activity may well have direct physiological implications in stroke and in Alzheimer's disease. HO acts as an antioxidant enzyme by degrading heme into iron, carbon monoxide, and biliverdin that is rapidly converted into bilirubin. Using mouse primary neuronal cultures, we demonstrated that PGs of the J series induce HO-1 in a dose-dependent manner (0, 0.5, 5, 10, 20, and 50 μg/ml) and that PGJ 2 and dPGJ2 were more potent than PGA2, dPGA2, PGD2, and PGE2. No significant effects were observed for HO-2 and actin expression. In regard to HO-3 expression found in rat, with its protein deducted sequence highly homologous to HO-2, no detection was observed in HO-2-/- mice, suggesting that HO-3 protein would not be present in mouse brain. We are proposing that several of the protective effects of PGJ2 could be mediated through beneficial actions of heme degradation and its metabolites. The design of new mimetics based on the cyclopentenone structure could be very useful as neuroprotective agents and be tested in animal models of stroke and Alzheimer's disease.",
keywords = "Alzheimer's disease, Antioxidant, Cerebral ischemia, Free radical, Iron, Neurodegeneration, Oxidative stress, Prostaglandin, Stroke",
author = "Hean Zhuang and Sokhon Pin and Xiaoling Li and Sylvain Dor{\'e}",
year = "2003",
month = "5",
language = "English (US)",
volume = "228",
pages = "499--505",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "0037-9727",
publisher = "Society for Experimental Biology and Medicine",
number = "5",

}

TY - JOUR

T1 - Regulation of heme oxygenase expression by cyclopentenone prostaglandins

AU - Zhuang, Hean

AU - Pin, Sokhon

AU - Li, Xiaoling

AU - Doré, Sylvain

PY - 2003/5

Y1 - 2003/5

N2 - Prostaglandins (PGs) originate from the degradation of membranar arachidonic acid by cyclooxygenases (COX-1 and COX-2). The prostaglandin actions in the nervous system are multiple and have been suggested to play a significant role in neurodegenerative disorders. Some PGs have been reported to be toxic and, interestingly, the cyclopentenone PGs have been reported to be cytoprotective at low concentration and could play a significant role in neuronal plasticity. They have been shown to be protective against oxidative stress injury; however, the cellular mechanisms of protection afforded by these PGs are still unclear. It is postulated that the cascade leading to neuronal cell death in acute and chronic neurodegenerative conditions, such as cerebral ischemia and Alzheimer's disease, would be mediated by free radical damage. We tested the hypothesis that the neuroprotective action of cyclopentanone could be caused partially by an induction of heme oxygenase 1 (HO-1). We and others have previously reported that modulation of HO total activity may well have direct physiological implications in stroke and in Alzheimer's disease. HO acts as an antioxidant enzyme by degrading heme into iron, carbon monoxide, and biliverdin that is rapidly converted into bilirubin. Using mouse primary neuronal cultures, we demonstrated that PGs of the J series induce HO-1 in a dose-dependent manner (0, 0.5, 5, 10, 20, and 50 μg/ml) and that PGJ 2 and dPGJ2 were more potent than PGA2, dPGA2, PGD2, and PGE2. No significant effects were observed for HO-2 and actin expression. In regard to HO-3 expression found in rat, with its protein deducted sequence highly homologous to HO-2, no detection was observed in HO-2-/- mice, suggesting that HO-3 protein would not be present in mouse brain. We are proposing that several of the protective effects of PGJ2 could be mediated through beneficial actions of heme degradation and its metabolites. The design of new mimetics based on the cyclopentenone structure could be very useful as neuroprotective agents and be tested in animal models of stroke and Alzheimer's disease.

AB - Prostaglandins (PGs) originate from the degradation of membranar arachidonic acid by cyclooxygenases (COX-1 and COX-2). The prostaglandin actions in the nervous system are multiple and have been suggested to play a significant role in neurodegenerative disorders. Some PGs have been reported to be toxic and, interestingly, the cyclopentenone PGs have been reported to be cytoprotective at low concentration and could play a significant role in neuronal plasticity. They have been shown to be protective against oxidative stress injury; however, the cellular mechanisms of protection afforded by these PGs are still unclear. It is postulated that the cascade leading to neuronal cell death in acute and chronic neurodegenerative conditions, such as cerebral ischemia and Alzheimer's disease, would be mediated by free radical damage. We tested the hypothesis that the neuroprotective action of cyclopentanone could be caused partially by an induction of heme oxygenase 1 (HO-1). We and others have previously reported that modulation of HO total activity may well have direct physiological implications in stroke and in Alzheimer's disease. HO acts as an antioxidant enzyme by degrading heme into iron, carbon monoxide, and biliverdin that is rapidly converted into bilirubin. Using mouse primary neuronal cultures, we demonstrated that PGs of the J series induce HO-1 in a dose-dependent manner (0, 0.5, 5, 10, 20, and 50 μg/ml) and that PGJ 2 and dPGJ2 were more potent than PGA2, dPGA2, PGD2, and PGE2. No significant effects were observed for HO-2 and actin expression. In regard to HO-3 expression found in rat, with its protein deducted sequence highly homologous to HO-2, no detection was observed in HO-2-/- mice, suggesting that HO-3 protein would not be present in mouse brain. We are proposing that several of the protective effects of PGJ2 could be mediated through beneficial actions of heme degradation and its metabolites. The design of new mimetics based on the cyclopentenone structure could be very useful as neuroprotective agents and be tested in animal models of stroke and Alzheimer's disease.

KW - Alzheimer's disease

KW - Antioxidant

KW - Cerebral ischemia

KW - Free radical

KW - Iron

KW - Neurodegeneration

KW - Oxidative stress

KW - Prostaglandin

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0037531138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037531138&partnerID=8YFLogxK

M3 - Article

C2 - 12709576

AN - SCOPUS:0037531138

VL - 228

SP - 499

EP - 505

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 0037-9727

IS - 5

ER -